Gingko Bioworks raises $350 million fund for biotech spinouts
October 9, 2019
Wearable device Fitbit to shift production out of China from January
October 9, 2019

Goldman evaluating role in China’s Megvii IPO after U.S. blacklist

Goldman Sachs Group Inc said on Tuesday it was reviewing its involvement in Megvii Technology Ltd’s planned initial public offering after the U.S. government placed the Chinese artificial intelligence firm on a human rights blacklist.

Powered by WPeMatico